244 results on '"Tang, Yong-Min"'
Search Results
2. Efficacy of inactivated SARS-CoV-2 vaccination in pediatric hematology/oncology patients: a real-world study
3. Prognostic performance of IL-6 and IL-10 in febrile pediatric hematology/oncology patients with normal procalcitonin
4. Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited
5. Pediatric blastic plasmacytoid dendritic cell neoplasm: report of four cases and review of literature
6. Prognostic performance of IL-6 and IL-10 in febrile pediatric hematology/oncology patients with normal procalcitonin
7. Dilemmas in diagnosis and management of hemophagocytic lymphohistiocytosis in children
8. Gene therapy for hemophilia B in immature mice using ScAAV-DJ/8-LP1-hFIXco vector
9. The effect of the plasma methotrexate concentration during high-dose methotrexate therapy in childhood acute lymphoblastic leukemia
10. Cytokine profiles as novel diagnostic markers of Epstein-Barr virus–associated hemophagocytic lymphohistiocytosis in children
11. The effect of the plasma methotrexate concentration during high-dose methotrexate therapy in childhood acute lymphoblastic leukemia.
12. The predictive utility of cytokines, procalcitonin and C-reactive protein among febrile pediatric hematology and oncology patients with severe sepsis or septic shock.
13. A new in-frame deletion in ribosomal protein S19 in a Chinese infant with Diamond-Blackfan anemia
14. Metagenomic next-generation sequencing for the diagnosis of fever of unknown origin in pediatric patients with hematological malignancy
15. Clinical features and prognostic implications of ecotropic viral integration site 1 (EVI1) in childhood acute lymphoblastic leukemia
16. Cytokine release syndrome in cancer immunotherapy with chimeric antigen receptor engineered T cells
17. Clinical features and prognostic implications of ecotropic viral integration site 1 (EVI1) in childhood acute lymphoblastic leukemia.
18. A multiplex cytokine score for the prediction of disease severity in pediatric hematology/oncology patients with septic shock
19. Absolute lymphocyte count is associated with minimal residual disease level in childhood B-cell precursor acute lymphoblastic leukemia
20. Prognostic significance of flow cytometric minimal residual disease assessment after the first induction course in Chinese childhood acute myeloid leukemia
21. Prognostic factors of early death in children with hemophagocytic lymphohistiocytosis
22. Prognostic significance of cytokine receptor-like factor 2 alterations in acute lymphoblastic leukemia: a meta-analysis
23. Day 22 of induction therapy is important for minimal residual disease assessment by flow cytometry in childhood acute lymphoblastic leukemia
24. The effect of the plasma methotrexate concentration during high-dose methotrexate therapy on prognosis of childhood acute lymphoblastic leukemia
25. Integration of Interleukin-6 Improves the Diagnostic Precision of Metagenomic Next-Generation Sequencing for Infection in Immunocompromised Children
26. Simple Evaluation of Clinical Situation and Subtypes of Pediatric Hemophagocytic Lymphohistiocytosis by Cytokine Patterns
27. Fulminant cytokine release syndrome in a paediatric patient with refractory Epstein–Barr virus-associated haemophagocytic lymphohistiocytosis receiving nivolumab treatment
28. Clinical features and prognostic impact of TCF3–PBX1 in childhood acute lymphoblastic leukemia: A single-center retrospective study of 837 patients from China
29. Serum creatinine and creatinine clearance for predicting plasma methotrexate concentrations after high-dose methotrexate chemotherapy for the treatment for childhood lymphoblastic malignancies
30. Coronin-1a is a potential therapeutic target for activated T cell-related immune disorders
31. Inflammatory cytokine measurement quickly discriminates gram-negative from gram-positive bacteremia in pediatric hematology/oncology patients with septic shock
32. Corticosteroid administration is associated with improved outcome of patients presenting high inflammatory cytokine levels during septic shock
33. High CD38 expression in childhood T-cell acute lymphoblastic leukemia is not associated with prognosis
34. Diagnostic Accuracy of a Specific Cytokine Pattern in Hemophagocytic Lymphohistiocytosis in Children
35. Dilemmas in diagnosis and management of hemophagocytic lymphohistiocytosis in children
36. Low expression of TET2 gene in pediatric acute lymphoblastic leukemia is associated with poor clinical outcome
37. Evaluation of IVIG response in relation to Th1/Th2 cytokines in pediatricm immune thrombocytopenia
38. A genetic analysis of children with Epstein-Barr virus-positive hemophagocytic lymphohistiocytosis and its association with T-helper type 1/T-helper type 2 cytokines.
39. Prognostic factors of early death in children with hemophagocytic lymphohistiocytosis
40. ETS-related gene is a novel prognostic factor in childhood acute lymphoblastic leukemia
41. The Effectiveness of Blinatumomab in Clearing Next-Generation Sequencing Measurable Residual Disease in Pediatric Patients with B-Cell Acute Lymphoblastic Leukemia
42. Use of flow cytometry to investigate the cytokine response pattern in infants with respiratory syncytial virus infection and bronchiolitis
43. Associations between inflammatory cytokines and organ damage in pediatric patients with hemophagocytic lymphohistiocytosis
44. Multiparameter comparative analysis reveals differential impacts of various cytokines on CART cell phenotype and function ex vivo and in vivo
45. Efficiency of interleukin 6 and interferon gamma in the differentiation of invasive pulmonary aspergillosis and pneumocystis pneumonia in pediatric oncology patients
46. Clinical Value of Assessing Cytokine Levels for the Differential Diagnosis of Bacterial Meningitis in a Pediatric Population
47. High expression of Midkine (MK) indicates poor prognosis in childhood acute lymphoblastic leukemia
48. Clinical presentation and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in China: A retrospective multicenter study.
49. The impact of IKZF1 deletion on the prognosis of acute lymphoblastic leukemia: An updated meta-analysis
50. Construction and Expression of a Novel Anti-CD14 Human-Mouse Chimeric Antibody Hm2F9
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.